Premarket Mover: Verve Therapeutics Inc (VERV) Up 0.32%

Verve Therapeutics Inc (VERV) has gained Tuesday morning, with the stock adding 0.32% in pre-market trading to 9.32. VERV's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, the stock ranks higher than 0% of stocks. Verve Therapeutics Inc has fallen 20.60% over the past month, closing at $11.52 on October 17. During this period of time, the stock fell as low as $8.84 and as high as $20.12. VERV has an average analyst recommendation of Strong Buy. The company has an average price target of $43.67.

VERV has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on VERV!

See Full VERV Report

Verve Therapeutics Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, VERV ranks better than 126% of stocks.

Important Dates for Investors in VERV:

-Verve Therapeutics Inc is set to release earnings on 2024-02-05. Over the last 12 months, the company has reported EPS of $-3.09. -We do not have a set dividend date for Verve Therapeutics Inc at this time. Click Here To Get The Full Report on Verve Therapeutics Inc (VERV)